Industry News

The latest medical device regulatory news, clinical trials, and market insights

Home / News
2,227 articles
Business & Finance

Illumi Medical Secures ¥340M in Series A First Close to Drive Global Expansion

Meta description: Illumi Medical closes first tranche of Series A funding at 340 million yen, adding new investors and targeting…

October 27, 2025 Dr. Hatem Rabeh
Business & Finance

roclub Secures $11.7 Million Series A to Accelerate U.S. Teleoperations in Medical Technology

Meta description: roclub secures $11.7 million in Series A funding to expand its U.S. teleoperations capabilities and address medical technologist…

October 27, 2025 Dr. Hatem Rabeh
Europe

Swissmedic Expands Therapeutic Indication for Palforzia®

Swissmedic, Switzerland’s agency for the authorization and supervision of therapeutic products, has announced an extension of the therapeutic indication for…

October 27, 2025 Dr. Hatem Rabeh
Europe

Swissmedic Announces Authorization of Ayvakyt®: A Clinical Update

Swissmedic, the Swiss agency for therapeutic products, has announced the first regulatory authorization for Ayvakyt®. This marks a significant milestone…

October 27, 2025 Dr. Hatem Rabeh
Europe

Swissmedic Grants Initial Authorization for Wainzua®: Key Regulatory Update

Swissmedic, the Swiss agency responsible for licensing and monitoring therapeutic products, has announced the initial authorization for Wainzua®. This development…

October 27, 2025 Dr. Hatem Rabeh
Europe

Tamsulosin and Its Association with Intraoperative Floppy Iris Syndrome: Swissmedic Insights

Swissmedic has issued an important notice about the risks of intraoperative floppy iris syndrome (IFIS) among patients undergoing cataract surgery…

October 27, 2025 Dr. Hatem Rabeh
Europe

Swissmedic Updates on Veterinary Drug Reactions: Key Insights from 2024 Reports

The latest vigilance report from Swissmedic highlights significant findings regarding adverse reactions to veterinary medicinal products reported in Switzerland during…

October 27, 2025 Dr. Hatem Rabeh
Clinical Trials

Clinical Rollout of the BioFire Emerging Coronavirus Panel: A Novel Diagnostic Device Study

Key players in clinical diagnostics are turning their attention to the BioFire Emerging Coronavirus Panel in a new prospective evaluation…

October 27, 2025 Dr. Hatem Rabeh
Clinical Trials

Clinical Trial Launches for Experimental Device Without FDA Approval

A new clinical trial has been announced involving an investigational medical device that has not yet been approved or cleared…

October 27, 2025 Dr. Hatem Rabeh
Clinical Trials

New Study Explores Biometric Vibration Mat’s Impact on Sleep and Recovery

A clinical trial is recruiting participants to examine the potential of a low-frequency whole-body vibration mat for sleep and daily…

October 27, 2025 Dr. Hatem Rabeh
Clinical Trials

Investigating rTMS as a Promising Intervention for Dysphagia in Parkinson’s Disease

Published on October 27, 2025: A completed clinical study delves into the potential of repetitive transcranial magnetic stimulation (rTMS) for…

October 27, 2025 Dr. Hatem Rabeh
Clinical Trials

Innovative Food-As-Medicine Program Targets Rural North Carolina’s Food Insecurity and Health Risks

Rural North Carolina is now the focus of an innovative clinical trial addressing food insecurity and associated health risks. Combing…

October 27, 2025 Dr. Hatem Rabeh
Loading more articles...
Scroll to Top